Proveblue (Methylene Blue) as an Antimalarial Agent: In Vitro Synergy with Dihydroartemisinin and Atorvastatin

Proveblue (international patent PCT/FR/2007/001193), which is a methylene blue preparation that complies with the European Pharmacopoeia and contains limited organic impurities and heavy metals of recognized toxicity, has previously been demonstrated to possess in vitro antimalarial activity (at a

[1]  S. Hoffman,et al.  Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue , 2011, Proceedings of the National Academy of Sciences.

[2]  Zu-feng Guo,et al.  A Partial Convergence in Action of Methylene Blue and Artemisinins: Antagonism with Chloroquine, a Reversal with Verapamil, and an Insight into the Antimalarial Activity of Chloroquine , 2011, ChemMedChem.

[3]  S. Briolant,et al.  In Vitro Activity of Proveblue (Methylene Blue) on Plasmodium falciparum Strains Resistant to Standard Antimalarial Drugs , 2011, Antimicrobial Agents and Chemotherapy.

[4]  S. Briolant,et al.  Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene. , 2010, The Journal of antimicrobial chemotherapy.

[5]  S. Briolant,et al.  Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum , 2010, Antimicrobial Agents and Chemotherapy.

[6]  S. Briolant,et al.  Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum , 2010, Malaria Journal.

[7]  S. Briolant,et al.  Atorvastatin as a Potential Antimalarial Drug: In Vitro Synergy in Combinational Therapy with Dihydroartemisinin , 2009, Antimicrobial Agents and Chemotherapy.

[8]  O. Müller,et al.  Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial , 2009, PloS one.

[9]  S. Briolant,et al.  Atorvastatin Is a Promising Partner for Antimalarial Drugs in Treatment of Plasmodium falciparum Malaria , 2009, Antimicrobial Agents and Chemotherapy.

[10]  Meili Baragatti,et al.  Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malaria. , 2008, Medicinal chemistry (Shariqah (United Arab Emirates)).

[11]  O. Müller,et al.  Safety and Efficacy of Methylene Blue Combined with Artesunate or Amodiaquine for Uncomplicated Falciparum Malaria: A Randomized Controlled Trial from Burkina Faso , 2008, PloS one.

[12]  E. Deharo,et al.  Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum. , 2007, Parasite.

[13]  S. Briolant,et al.  Atorvastatin Is 10-Fold More Active In Vitro than Other Statins against Plasmodium falciparum , 2007, Antimicrobial Agents and Chemotherapy.

[14]  O. Müller,et al.  Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine , 2006, Malaria Journal.

[15]  W. Haefeli,et al.  In Vitro Assessment of Methylene Blue on Chloroquine-Sensitive and -Resistant Plasmodium falciparum Strains Reveals Synergistic Action with Artemisinins , 2005, Antimicrobial Agents and Chemotherapy.